![European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies](https://www.ecco-ibd.eu/images/6_Publication/6_2_ECCO_News/ECCO_News_Images/2021_Issue_3/Nestle/Graphic%203_ECCO.png)
European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies
![Natalia Queiroz on Twitter: Natalia Queiroz on Twitter:](https://pbs.twimg.com/media/EJrhZQtW4AUQyIq.jpg:large)
Natalia Queiroz on Twitter: "👇🏻👇🏻👇🏻 ECCO guidelines on Rx in #CD: ✓induction (mod-sev) - anti-TNF or UST or VEDO. IFX Combo, ADA mono - anti-TNF failure: UST or VEDO ✓maintenance - no
![PDF) Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: Medical treatment PDF) Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: Medical treatment](https://i1.rgstatic.net/publication/352704305_Biologics_recommendations_in_the_ECCO_guidelines_on_therapeutics_in_Crohn's_disease_Medical_treatment/links/60d9c15392851ca9449080ce/largepreview.png)
PDF) Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: Medical treatment
![PDF) Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group (Dietitians of ECCO) PDF) Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group (Dietitians of ECCO)](https://i1.rgstatic.net/publication/320131724_Research_Gaps_in_Diet_and_Nutrition_in_Inflammatory_Bowel_Disease_A_Topical_Review_by_D-ECCO_Working_Group_Dietitians_of_ECCO/links/5c62a57645851582c3e1b7fd/largepreview.png)
PDF) Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group (Dietitians of ECCO)
![PDF) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease | Jiri Bronsky, Jorge Amil, Jaroslaw Kierkus, Gábor Veres, and Johanna Escher - Academia.edu PDF) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease | Jiri Bronsky, Jorge Amil, Jaroslaw Kierkus, Gábor Veres, and Johanna Escher - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/40333028/mini_magick20190221-19344-hsnm4k.png?1550766493)
PDF) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease | Jiri Bronsky, Jorge Amil, Jaroslaw Kierkus, Gábor Veres, and Johanna Escher - Academia.edu
![Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1873994614001482-gr2.jpg)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect
![Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut](https://gut.bmj.com/content/gutjnl/70/6/1044/F1.large.jpg)
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Resul
![First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | Nature Reviews Gastroenterology & Hepatology First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrgastro.2013.31/MediaObjects/41575_2013_Article_BFnrgastro201331_Fig1_HTML.jpg)
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | Nature Reviews Gastroenterology & Hepatology
![ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/04/news-ecco-1080x675.jpg)